Lipid Nanoparticles Carrying Essential Oils for Multiple Applications as Antimicrobials.

Elenice Francisco da Silva, Fernanda Aparecida Longato Dos Santos, Henrique Machado Pires, Luciana Machado Bastos, Lígia Nunes de Morais Ribeiro
Author Information
  1. Elenice Francisco da Silva: Institute of Biotechnology, Federal University of Uberlandia, Uberlandia 38405-302, Brazil.
  2. Fernanda Aparecida Longato Dos Santos: School of Veterinary Medicine, Federal University of Uberlandia, Uberlandia 38402-018, Brazil.
  3. Henrique Machado Pires: Vaccine Development Laboratory, Butantan Institute, São Paulo 05503-900, Brazil.
  4. Luciana Machado Bastos: Institute of Biotechnology, Federal University of Uberlandia, Uberlandia 38405-302, Brazil.
  5. Lígia Nunes de Morais Ribeiro: Institute of Biotechnology, Federal University of Uberlandia, Uberlandia 38405-302, Brazil. ORCID

Abstract

Lipid nanoparticles (LNPs) are versatile delivery systems with high interest because they allow the release of hydrophobic and hydrophilic molecules, such as essential oils (EOs) and plant extracts. This review covers published works between 2019 and 2024 that have reported the use of essential EO-based LNPs with antimicrobial properties and applications in human and animal health, as well as biopesticides. In the human healthcare field, reports have addressed the effect of encapsulating EOs in lipid nanosystems with antiviral, antibacterial, antiprotozoal and antifungal activities. In animal care, this still needs to be more deeply explored while looking for more sustainable alternatives against different types of parasites that affect animal health. Overall, the antibacterial activities of LNPs carrying EOs are described as alternatives to the use of synthetic antibiotics. In the field of agriculture, studies showed that these approaches in the control of phytopathogens and other pests that affect food production. There is a growing demand for innovative and more sustainable technologies. However, there are still some challenges to be overcome in order to allow these innovations to reach the market.

Keywords

References

  1. Molecules. 2023 Aug 01;28(15): [PMID: 37570781]
  2. BMC Complement Med Ther. 2024 Apr 8;24(1):155 [PMID: 38589838]
  3. Plant Physiol Biochem. 2024 Feb;207:108370 [PMID: 38271861]
  4. Nanomaterials (Basel). 2020 Jan 12;10(1): [PMID: 31940900]
  5. Microorganisms. 2022 Jul 26;10(8): [PMID: 35893562]
  6. Nanomaterials (Basel). 2020 Feb 07;10(2): [PMID: 32046201]
  7. J Microencapsul. 2020 Aug;37(5):394-402 [PMID: 32400238]
  8. Front Cell Infect Microbiol. 2024 Jan 09;13:1328519 [PMID: 38264725]
  9. Adv Colloid Interface Sci. 2022 May;303:102655 [PMID: 35364434]
  10. Appl Microbiol Biotechnol. 2022 Apr;106(7):2311-2335 [PMID: 35312826]
  11. Pharmaceutics. 2024 Jun 27;16(7): [PMID: 39065561]
  12. Front Cell Infect Microbiol. 2021 Jan 08;10:571040 [PMID: 33489930]
  13. Mol Pharm. 2021 Aug 2;18(8):2867-2888 [PMID: 34264684]
  14. Plants (Basel). 2023 Oct 25;12(21): [PMID: 37960039]
  15. Poult Sci. 2023 Jun;102(6):102683 [PMID: 37120892]
  16. Front Plant Sci. 2022 Apr 29;13:874221 [PMID: 35574070]
  17. Pharmaceutics. 2021 Nov 17;13(11): [PMID: 34834365]
  18. PLoS One. 2024 Nov 11;19(11):e0313517 [PMID: 39527597]
  19. Int J Pharm. 2024 May 25;657:124149 [PMID: 38677395]
  20. Pharmaceutics. 2019 May 13;11(5): [PMID: 31085997]
  21. Colloids Surf B Biointerfaces. 2024 May;237:113835 [PMID: 38479260]
  22. Phytomedicine. 2023 Jul 25;116:154848 [PMID: 37163901]
  23. Pest Manag Sci. 2024 Feb;80(2):452-462 [PMID: 37721471]
  24. Pharmaceutics. 2020 Aug 14;12(8): [PMID: 32823823]
  25. Pharmaceutics. 2022 Dec 01;14(12): [PMID: 36559176]
  26. J Microencapsul. 2024 Jun;41(4):284-295 [PMID: 38686964]
  27. Pharmaceutics. 2024 Apr 24;16(5): [PMID: 38794244]
  28. Pharmaceutics. 2024 Jul 11;16(7): [PMID: 39065619]
  29. Turk J Pharm Sci. 2024 Nov 21;21(5):456-462 [PMID: 39569700]
  30. J Control Release. 2024 Sep;373:617-639 [PMID: 39002799]
  31. J Control Release. 2024 Dec;376:1025-1038 [PMID: 39489466]
  32. Molecules. 2021 May 13;26(10): [PMID: 34068039]
  33. Molecules. 2022 Mar 17;27(6): [PMID: 35335302]
  34. Pharmaceutics. 2022 Jan 13;14(1): [PMID: 35057078]
  35. Pharmaceutics. 2021 Mar 12;13(3): [PMID: 33809385]
  36. Antibiotics (Basel). 2024 Jun 19;13(6): [PMID: 38927234]
  37. Sci Rep. 2023 Jan 30;13(1):1705 [PMID: 36717735]
  38. Animals (Basel). 2024 Jul 17;14(14): [PMID: 39061546]
  39. PLoS One. 2021 Jul 09;16(7):e0254225 [PMID: 34242328]
  40. Nat Nanotechnol. 2024 Nov;19(11):1597-1611 [PMID: 39242807]
  41. Int J Pharm. 2021 May 15;601:120538 [PMID: 33781879]
  42. Front Chem. 2020 Nov 12;8:589503 [PMID: 33282832]
  43. Environ Sci Pollut Res Int. 2024 Jul;31(34):46546-46557 [PMID: 37074605]
  44. Heliyon. 2024 May 22;10(11):e31728 [PMID: 38845989]
  45. Int J Mol Sci. 2023 Jan 02;24(1): [PMID: 36614230]
  46. Molecules. 2021 Jun 25;26(13): [PMID: 34202405]
  47. Biomolecules. 2024 Jul 15;14(7): [PMID: 39062565]
  48. Pharmaceuticals (Basel). 2021 Aug 24;14(9): [PMID: 34577536]
  49. Molecules. 2021 Oct 22;26(21): [PMID: 34770801]
  50. Int J Pharm. 2024 Sep 5;662:124464 [PMID: 39033939]
  51. Environ Pollut. 2021 Nov 15;289:117817 [PMID: 34333268]
  52. Nanomaterials (Basel). 2019 Apr 19;9(4): [PMID: 31010180]
  53. Adv Drug Deliv Rev. 2020;154-155:102-122 [PMID: 32650041]
  54. J Microbiol Immunol Infect. 2023 Feb;56(1):150-162 [PMID: 35864068]
  55. Pharmaceuticals (Basel). 2023 Aug 14;16(8): [PMID: 37631066]
  56. Molecules. 2023 Apr 27;28(9): [PMID: 37175176]
  57. Exp Appl Acarol. 2021 May;84(1):241-262 [PMID: 33934282]
  58. Heliyon. 2024 Aug 08;10(16):e35967 [PMID: 39224365]
  59. Drug Deliv. 2022 Dec;29(1):1007-1024 [PMID: 35363104]
  60. Pharmaceutics. 2023 Jul 29;15(8): [PMID: 37631258]
  61. Int J Biol Macromol. 2024 Jan;254(Pt 2):127904 [PMID: 37939770]
  62. Int J Pharm. 2022 Aug 25;624:121878 [PMID: 35636629]
  63. Pharmaceuticals (Basel). 2020 Aug 28;13(9): [PMID: 32872140]
  64. ACS Mater Au. 2023 Aug 21;3(6):600-619 [PMID: 38089666]
  65. Pharmaceuticals (Basel). 2021 Oct 26;14(11): [PMID: 34832865]
  66. Antibiotics (Basel). 2021 Oct 26;10(11): [PMID: 34827238]
  67. Mater Today Bio. 2023 Oct 21;23:100837 [PMID: 37953758]
  68. Mycopathologia. 2016 Dec;181(11-12):865-869 [PMID: 27544535]
  69. Sci Total Environ. 2024 Mar 10;915:170113 [PMID: 38232846]
  70. Expert Opin Drug Deliv. 2019 Jul;16(7):701-714 [PMID: 31172838]
  71. Vaccines (Basel). 2021 Apr 08;9(4): [PMID: 33918072]
  72. Drug Deliv. 2021 Dec;28(1):463-477 [PMID: 33620004]
  73. Heliyon. 2021 Jan 19;7(1):e05896 [PMID: 33521347]
  74. Antibiotics (Basel). 2021 Dec 27;11(1): [PMID: 35052903]
  75. Pharmaceutics. 2023 May 25;15(6): [PMID: 37376042]

Grants

  1. 408640/2022-7/National Council for Scientific and Technological Development

Word Cloud

Created with Highcharts 10.0.0LNPsessentialEOsanimalLipidnanoparticlesallowuseantimicrobialhumanhealthfieldlipidantibacterialactivitiesstillsustainablealternativesaffectversatiledeliverysystemshighinterestreleasehydrophobichydrophilicmoleculesoilsplantextractsreviewcoverspublishedworks20192024reportedEO-basedpropertiesapplicationswellbiopesticideshealthcarereportsaddressedeffectencapsulatingnanosystemsantiviralantiprotozoalantifungalcareneedsdeeplyexploredlookingdifferenttypesparasitesOverallcarryingdescribedsyntheticantibioticsagriculturestudiesshowedapproachescontrolphytopathogenspestsfoodproductiongrowingdemandinnovativetechnologiesHoweverchallengesovercomeorderinnovationsreachmarketNanoparticlesCarryingEssentialOilsMultipleApplicationsAntimicrobialsactivityoil

Similar Articles

Cited By